Search research articles
Contact Us
Filters
Showing results (401-410 of 410) with videos related to
Page
of 41
Sort By:
You have reached the last page of results.
This site can display upto 410 results.
The New England Journal of Medicine
|
December 17, 1998
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators
J N Cohn, S O Goldstein, B H Greenberg, et al.
The American Journal of Cardiology
|
January 15, 1990
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure
M A Fifer, C R Molina, A C Quiroz, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
March 8, 2000
The first report of the Systolic and Pulse Pressure (SYPP) Working Group
H R Black, L H Kuller, M F O'Rourke, et al.
The American Journal of Cardiology
|
August 1, 1982
Task force IV: pharmacologic interventions. Emergency cardiac care
R M Gunnar, C T Lambrew, W Abrams, et al.
Journal of the American College of Cardiology
|
May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group
M B Fowler, M Vera-Llonch, G Oster, et al.
The New England Journal of Medicine
|
May 13, 1982
Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study
J N Cohn, J A Franciosa, G S Francis, et al.
Circulation
|
February 18, 1997
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research
J N Cohn, M R Bristow, K R Chien, et al.
Journal of Cardiac Failure
|
October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group
J N Cohn, M B Fowler, M R Bristow, et al.
Circulation
|
December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group
W S Colucci, M Packer, M R Bristow, et al.
Congestive Heart Failure (Greenwich, Conn.)
|
February 6, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination
C V Leier, J B Young, T B Levine, et al.
Page
of 41
Search research articles
Search
Showing results (401-410 of 410) with videos related to
Sort By:
Page
of 41
You have reached the last page of results.
This site can display upto 410 results.
The New England Journal of Medicine
|
December 17, 1998
A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators
J N Cohn, S O Goldstein, B H Greenberg, et al.
The American Journal of Cardiology
|
January 15, 1990
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure
M A Fifer, C R Molina, A C Quiroz, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
March 8, 2000
The first report of the Systolic and Pulse Pressure (SYPP) Working Group
H R Black, L H Kuller, M F O'Rourke, et al.
The American Journal of Cardiology
|
August 1, 1982
Task force IV: pharmacologic interventions. Emergency cardiac care
R M Gunnar, C T Lambrew, W Abrams, et al.
Journal of the American College of Cardiology
|
May 10, 2001
Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group
M B Fowler, M Vera-Llonch, G Oster, et al.
The New England Journal of Medicine
|
May 13, 1982
Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study
J N Cohn, J A Franciosa, G S Francis, et al.
Circulation
|
February 18, 1997
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research
J N Cohn, M R Bristow, K R Chien, et al.
Journal of Cardiac Failure
|
October 23, 1997
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group
J N Cohn, M B Fowler, M R Bristow, et al.
Circulation
|
December 1, 1996
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group
W S Colucci, M Packer, M R Bristow, et al.
Congestive Heart Failure (Greenwich, Conn.)
|
February 6, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination
C V Leier, J B Young, T B Levine, et al.
Page
of 41